| Morgan Zentner, ARNP | |
|
205 Lilly Rd Ne, Bldg B Suite C, Olympia, WA 98506-5069 | |
| (360) 456-0555 | |
| (360) 456-0721 |
| Full Name | Morgan Zentner |
|---|---|
| Gender | Female |
| Speciality | Certified Nurse Midwife (cnm) |
| Experience | 10 Years |
| Location | 205 Lilly Rd Ne, Olympia, Washington |
| Accepts Medicare Assignments | May be. She may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013324656 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | AP60483956 (Washington) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | AP60525849 (Washington) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Amber Campbell Arnp | 2668869470 | 5 |
News Archive
Even mild depressive symptoms can weaken the outcome of lumbar spinal stenosis surgery, according to a recent study completed at the University of Eastern Finland and Kuopio University Hospital. Patients with depressive symptoms had a weaker functional capacity post-surgery even five years after surgery.
There is little argument among experts that autism spectrum disorders (ASD), complex developmental disabilities that vary widely in their severity, are caused by both genetic and environmental factors. Advances in genome sequencing now permit scientists to uncover specific mutations in DNA that are associated with ASD at unprecedented resolution. Such data are vital to understanding the genetic basis of the disorder.
Linagliptin has been approved since August 2011 to improve blood glucose control in adults with type 2 diabetes. The assessment of the new dossier according to the German Act on the Reform of the Market for Medicinal Products (AMNOG) again showed that no added benefit of the drug over the appropriate comparator therapy (ACT) can be determined, because the pharmaceutical company has not submitted any relevant studies.
Genome editing using CRISPR/Cas9 "gene scissors" is a powerful tool for biological discovery and for identifying novel drug targets.
› Verified 4 days ago
| Entity Name | Kaiser Foundation Health Plan Of Washington |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396810701 PECOS PAC ID: 9032022579 Enrollment ID: O20031112000454 |
News Archive
Even mild depressive symptoms can weaken the outcome of lumbar spinal stenosis surgery, according to a recent study completed at the University of Eastern Finland and Kuopio University Hospital. Patients with depressive symptoms had a weaker functional capacity post-surgery even five years after surgery.
There is little argument among experts that autism spectrum disorders (ASD), complex developmental disabilities that vary widely in their severity, are caused by both genetic and environmental factors. Advances in genome sequencing now permit scientists to uncover specific mutations in DNA that are associated with ASD at unprecedented resolution. Such data are vital to understanding the genetic basis of the disorder.
Linagliptin has been approved since August 2011 to improve blood glucose control in adults with type 2 diabetes. The assessment of the new dossier according to the German Act on the Reform of the Market for Medicinal Products (AMNOG) again showed that no added benefit of the drug over the appropriate comparator therapy (ACT) can be determined, because the pharmaceutical company has not submitted any relevant studies.
Genome editing using CRISPR/Cas9 "gene scissors" is a powerful tool for biological discovery and for identifying novel drug targets.
› Verified 4 days ago
| Entity Name | Olympia Obstetrics & Gynecology Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922045848 PECOS PAC ID: 8426086802 Enrollment ID: O20050727000693 |
News Archive
Even mild depressive symptoms can weaken the outcome of lumbar spinal stenosis surgery, according to a recent study completed at the University of Eastern Finland and Kuopio University Hospital. Patients with depressive symptoms had a weaker functional capacity post-surgery even five years after surgery.
There is little argument among experts that autism spectrum disorders (ASD), complex developmental disabilities that vary widely in their severity, are caused by both genetic and environmental factors. Advances in genome sequencing now permit scientists to uncover specific mutations in DNA that are associated with ASD at unprecedented resolution. Such data are vital to understanding the genetic basis of the disorder.
Linagliptin has been approved since August 2011 to improve blood glucose control in adults with type 2 diabetes. The assessment of the new dossier according to the German Act on the Reform of the Market for Medicinal Products (AMNOG) again showed that no added benefit of the drug over the appropriate comparator therapy (ACT) can be determined, because the pharmaceutical company has not submitted any relevant studies.
Genome editing using CRISPR/Cas9 "gene scissors" is a powerful tool for biological discovery and for identifying novel drug targets.
› Verified 4 days ago
| Entity Name | Julie A Dybbro Arnp Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548466253 PECOS PAC ID: 9830119288 Enrollment ID: O20051130000176 |
News Archive
Even mild depressive symptoms can weaken the outcome of lumbar spinal stenosis surgery, according to a recent study completed at the University of Eastern Finland and Kuopio University Hospital. Patients with depressive symptoms had a weaker functional capacity post-surgery even five years after surgery.
There is little argument among experts that autism spectrum disorders (ASD), complex developmental disabilities that vary widely in their severity, are caused by both genetic and environmental factors. Advances in genome sequencing now permit scientists to uncover specific mutations in DNA that are associated with ASD at unprecedented resolution. Such data are vital to understanding the genetic basis of the disorder.
Linagliptin has been approved since August 2011 to improve blood glucose control in adults with type 2 diabetes. The assessment of the new dossier according to the German Act on the Reform of the Market for Medicinal Products (AMNOG) again showed that no added benefit of the drug over the appropriate comparator therapy (ACT) can be determined, because the pharmaceutical company has not submitted any relevant studies.
Genome editing using CRISPR/Cas9 "gene scissors" is a powerful tool for biological discovery and for identifying novel drug targets.
› Verified 4 days ago
| Entity Name | Amber Campbell Arnp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477200673 PECOS PAC ID: 2668869470 Enrollment ID: O20220426001894 |
News Archive
Even mild depressive symptoms can weaken the outcome of lumbar spinal stenosis surgery, according to a recent study completed at the University of Eastern Finland and Kuopio University Hospital. Patients with depressive symptoms had a weaker functional capacity post-surgery even five years after surgery.
There is little argument among experts that autism spectrum disorders (ASD), complex developmental disabilities that vary widely in their severity, are caused by both genetic and environmental factors. Advances in genome sequencing now permit scientists to uncover specific mutations in DNA that are associated with ASD at unprecedented resolution. Such data are vital to understanding the genetic basis of the disorder.
Linagliptin has been approved since August 2011 to improve blood glucose control in adults with type 2 diabetes. The assessment of the new dossier according to the German Act on the Reform of the Market for Medicinal Products (AMNOG) again showed that no added benefit of the drug over the appropriate comparator therapy (ACT) can be determined, because the pharmaceutical company has not submitted any relevant studies.
Genome editing using CRISPR/Cas9 "gene scissors" is a powerful tool for biological discovery and for identifying novel drug targets.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Morgan Zentner, ARNP 200 Lilly Rd Ne Ste B, Olympia, WA 98506-5080 Ph: (360) 754-9409 | Morgan Zentner, ARNP 205 Lilly Rd Ne, Bldg B Suite C, Olympia, WA 98506-5069 Ph: (360) 456-0555 |
News Archive
Even mild depressive symptoms can weaken the outcome of lumbar spinal stenosis surgery, according to a recent study completed at the University of Eastern Finland and Kuopio University Hospital. Patients with depressive symptoms had a weaker functional capacity post-surgery even five years after surgery.
There is little argument among experts that autism spectrum disorders (ASD), complex developmental disabilities that vary widely in their severity, are caused by both genetic and environmental factors. Advances in genome sequencing now permit scientists to uncover specific mutations in DNA that are associated with ASD at unprecedented resolution. Such data are vital to understanding the genetic basis of the disorder.
Linagliptin has been approved since August 2011 to improve blood glucose control in adults with type 2 diabetes. The assessment of the new dossier according to the German Act on the Reform of the Market for Medicinal Products (AMNOG) again showed that no added benefit of the drug over the appropriate comparator therapy (ACT) can be determined, because the pharmaceutical company has not submitted any relevant studies.
Genome editing using CRISPR/Cas9 "gene scissors" is a powerful tool for biological discovery and for identifying novel drug targets.
› Verified 4 days ago
Karen Yepez, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 500 Lilly Rd Ne Ste 201, Olympia, WA 98506 Phone: 360-413-8272 Fax: 360-413-8878 | |
Ms. Melinda Anne Harris-moulton, MSN, ARNP, FNP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 5201 Dolphin Ln Nw, Olympia, WA 98502 Phone: 360-866-8143 | |
Katelin Petrin, CPNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 3434 12th Ave Ne, Olympia, WA 98506 Phone: 360-413-8470 Fax: 360-413-8490 | |
Michelle Jennings Hood, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 3920 Capital Mall Dr Sw Ste 400, Olympia, WA 98502 Phone: 360-705-1259 | |
Kimberly E Riano, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2950 Limited Ln Nw, Olympia, WA 98502 Phone: 360-706-2763 Fax: 360-350-0735 | |
Dara S Bernal, AP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 3516 7th Ave Sw, Olympia, WA 98502 Phone: 360-489-2906 | |
Madeleine Reed, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 209 Lilly Rd Ne Ste B, Olympia, WA 98506 Phone: 604-138-2503 |